To define the prognostic role in DLBCL, we retrospectively analyzed the clinical data of DLBCL patients, detected CDC6 expression by immunohistochemistry, and correlated CDC6 expression with clinicopathological features and prognosis of patients with DLBCL. The gene discussed is CDC6; the disease is diffuse large B-cell lymphoma.